EUS and Its Role in Pancreatic Cancer

  • Tobias Grote
  • Thomas Mathias Gress
Reference work entry


Endosocopic ultrasound (EUS) has become an indispensable tool in pancreatic diseases especially in cancer. This article provides an overview about basic principles as well as current developments in the field. It reviews recent literature regarding the use of EUS in pancreatic cancer. The key focus is on EUS-guided tissue sampling by EUS-fine-needle aspiration (EUS-FNA). Further main aspects include cystic pancreatic neoplasias, screening of individuals at risk for familial pancreatic cancer, and EUS-guided therapy.


Pancreatic cancer Endoscopic ultrasound (EUS) EUS-fine-needle aspiration (EUS-FNA) Staging Cystic pancreatic neoplasia EUS-guided therapy 


  1. 1.
    Committee ASoP, Eloubeidi MA, Decker GA, Chandrasekhara V, Chathadi KV, Early DS, et al. The role of endoscopy in the evaluation and management of patients with solid pancreatic neoplasia. Gastrointest Endosc. 2016;83(1):17–28.CrossRefGoogle Scholar
  2. 2.
    Committee AT, Murad FM, Komanduri S, Abu Dayyeh BK, Chauhan SS, Enestvedt BK, et al. Echoendoscopes. Gastrointest Endosc. 2015;82(2):189–202.CrossRefGoogle Scholar
  3. 3.
    Shin EJ, Topazian M, Goggins MG, Syngal S, Saltzman JR, Lee JH, et al. Linear-array EUS improves detection of pancreatic lesions in high-risk individuals: a randomized tandem study. Gastrointest Endosc. 2015;82(5):812–8.CrossRefGoogle Scholar
  4. 4.
    Hawes RHFP, Varadarajulu S. Endosonography. 3rd ed. Oxford: Elsevier Ltd; 2014.Google Scholar
  5. 5.
    Aslanian H, Salem R, Lee J, Andersen D, Robert M, Topazian M. EUS diagnosis of vascular invasion in pancreatic cancer: surgical and histologic correlates. Am J Gastroenterol. 2005;100(6):1381–5.CrossRefGoogle Scholar
  6. 6.
    DeWitt J, Devereaux B, Chriswell M, McGreevy K, Howard T, Imperiale TF, et al. Comparison of endoscopic ultrasonography and multidetector computed tomography for detecting and staging pancreatic cancer. Ann Intern Med. 2004;141(10):753–63.CrossRefGoogle Scholar
  7. 7.
    Dewitt J, Devereaux BM, Lehman GA, Sherman S, Imperiale TF. Comparison of endoscopic ultrasound and computed tomography for the preoperative evaluation of pancreatic cancer: a systematic review. Clin Gastroenterol Hepatol. 2006;4(6):717–725. quiz 664.CrossRefGoogle Scholar
  8. 8.
    Fisher JM, Gordon SR, Gardner TB. The impact of prior biliary stenting on the accuracy and complication rate of endoscopic ultrasound fine-needle aspiration for diagnosing pancreatic adenocarcinoma. Pancreas. 2011;40(1):21–4.CrossRefGoogle Scholar
  9. 9.
    Chang KJ, Albers CG, Erickson RA, Butler JA, Wuerker RB, Lin F. Endoscopic ultrasound-guided fine needle aspiration of pancreatic carcinoma. Am J Gastroenterol. 1994;89(2):263–6.PubMedGoogle Scholar
  10. 10.
    Wiersema MJ, Vilmann P, Giovannini M, Chang KJ, Wiersema LM. Endosonography-guided fine-needle aspiration biopsy: diagnostic accuracy and complication assessment. Gastroenterology. 1997;112(4):1087–95.CrossRefGoogle Scholar
  11. 11.
    Hartwig W, Schneider L, Diener MK, Bergmann F, Buchler MW, Werner J. Preoperative tissue diagnosis for tumours of the pancreas. Br J Surg. 2009;96(1):5–20.CrossRefGoogle Scholar
  12. 12.
    Seufferlein T, Porzner M, Becker T, Budach V, Ceyhan G, Esposito I, et al. S3-guideline exocrine pancreatic cancer. Z Gastroenterol. 2013;51(12):1395–440.CrossRefGoogle Scholar
  13. 13.
    Shimosegawa T, Chari ST, Frulloni L, Kamisawa T, Kawa S, Mino-Kenudson M, et al. International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the international association of pancreatology. Pancreas. 2011;40(3):352–8.CrossRefGoogle Scholar
  14. 14.
    Tanaka M, Fernandez-del Castillo C, Adsay V, Chari S, Falconi M, Jang JY, et al. International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology. 2012;12(3):183–97.CrossRefGoogle Scholar
  15. 15.
    Crane CH, Varadhachary G, Wolff RA, Pisters PW, Evans DB. The argument for pre-operative chemoradiation for localized, radiographically resectable pancreatic cancer. Best Pract Res Clin Gastroenterol. 2006;20(2):365–82.CrossRefGoogle Scholar
  16. 16.
    Eloubeidi MA, Chen VK, Eltoum IA, Jhala D, Chhieng DC, Jhala N, et al. Endoscopic ultrasound-guided fine needle aspiration biopsy of patients with suspected pancreatic cancer: diagnostic accuracy and acute and 30-day complications. Am J Gastroenterol. 2003;98(12):2663–8.PubMedGoogle Scholar
  17. 17.
    Lai R, Stanley MW, Bardales R, Linzie B, Mallery S. Endoscopic ultrasound-guided pancreatic duct aspiration: diagnostic yield and safety. Endoscopy. 2002;34(9):715–20.CrossRefGoogle Scholar
  18. 18.
    Chen VK, Arguedas MR, Kilgore ML, Eloubeidi MA. A cost-minimization analysis of alternative strategies in diagnosing pancreatic cancer. Am J Gastroenterol. 2004;99(11):2223–34.CrossRefGoogle Scholar
  19. 19.
    Erickson RA, Sayage-Rabie L, Beissner RS. Factors predicting the number of EUS-guided fine-needle passes for diagnosis of pancreatic malignancies. Gastrointest Endosc. 2000;51(2):184–90.CrossRefGoogle Scholar
  20. 20.
    Moller K, Papanikolaou IS, Toermer T, Delicha EM, Sarbia M, Schenck U, et al. EUS-guided FNA of solid pancreatic masses: high yield of 2 passes with combined histologic-cytologic analysis. Gastrointest Endosc. 2009;70(1):60–9.CrossRefGoogle Scholar
  21. 21.
    Collins BT, Murad FM, Wang JF, Bernadt CT. Rapid on-site evaluation for endoscopic ultrasound-guided fine-needle biopsy of the pancreas decreases the incidence of repeat biopsy procedures. Cancer Cytopathol. 2013;121(9):518–24.CrossRefGoogle Scholar
  22. 22.
    Layfield LJ, Bentz JS, Gopez EV. Immediate on-site interpretation of fine-needle aspiration smears: a cost and compensation analysis. Cancer. 2001;93(5):319–22.CrossRefGoogle Scholar
  23. 23.
    Aadam AA, Wani S, Amick A, Shah JN, Bhat YM, Hamerski CM, et al. A randomized controlled cross-over trial and cost analysis comparing endoscopic ultrasound fine needle aspiration and fine needle biopsy. Endosc Int Open. 2016;4(5):E497–505.CrossRefGoogle Scholar
  24. 24.
    Kamata K, Kitano M, Yasukawa S, Kudo M, Chiba Y, Ogura T, et al. Histologic diagnosis of pancreatic masses using 25-gauge endoscopic ultrasound needles with and without a core trap: a multicenter randomized trial. Endoscopy. 2016;48(7):632–8.CrossRefGoogle Scholar
  25. 25.
    Bang JY, Hawes R, Varadarajulu S. A meta-analysis comparing ProCore and standard fine-needle aspiration needles for endoscopic ultrasound-guided tissue acquisition. Endoscopy. 2016;48(4):339–49.PubMedGoogle Scholar
  26. 26.
    Levy MJ. Endoscopic ultrasound-guided trucut biopsy of the pancreas: prospects and problems. Pancreatology. 2007;7(2–3):163–6.CrossRefGoogle Scholar
  27. 27.
    Aithal GP, Anagnostopoulos GK, Tam W, Dean J, Zaitoun A, Kocjan G, et al. EUS-guided tissue sampling: comparison of “dual sampling” (Trucut biopsy plus FNA) with “sequential sampling” (Trucut biopsy and then FNA as required). Endoscopy. 2007;39(8):725–30.CrossRefGoogle Scholar
  28. 28.
    Mizuno N, Bhatia V, Hosoda W, Sawaki A, Hoki N, Hara K, et al. Histological diagnosis of autoimmune pancreatitis using EUS-guided trucut biopsy: a comparison study with EUS-FNA. J Gastroenterol. 2009;44(7):742–50.CrossRefGoogle Scholar
  29. 29.
    Shah SM, Ribeiro A, Levi J, Jorda M, Rocha-Lima C, Sleeman D, et al. EUS-guided fine needle aspiration with and without trucut biopsy of pancreatic masses. JOP. 2008;9(4):422–30.PubMedGoogle Scholar
  30. 30.
    Varadarajulu S, Bang JY, Hebert-Magee S. Assessment of the technical performance of the flexible 19-gauge EUS-FNA needle. Gastrointest Endosc. 2012;76(2):336–43.CrossRefGoogle Scholar
  31. 31.
    Eloubeidi MA, Tamhane A, Varadarajulu S, Wilcox CM. Frequency of major complications after EUS-guided FNA of solid pancreatic masses: a prospective evaluation. Gastrointest Endosc. 2006;63(4):622–9.CrossRefGoogle Scholar
  32. 32.
    Bournet B, Migueres I, Delacroix M, Vigouroux D, Bornet JL, Escourrou J, et al. Early morbidity of endoscopic ultrasound: 13 year’s experience at a referral center. Endoscopy. 2006;38(4):349–54.CrossRefGoogle Scholar
  33. 33.
    Eloubeidi MA, Gress FG, Savides TJ, Wiersema MJ, Kochman ML, Ahmad NA, et al. Acute pancreatitis after EUS-guided FNA of solid pancreatic masses: a pooled analysis from EUS centers in the United States. Gastrointest Endosc. 2004;60(3):385–9.CrossRefGoogle Scholar
  34. 34.
    Jenssen C, Alvarez-Sanchez MV, Napoleon B, Faiss S. Diagnostic endoscopic ultrasonography: assessment of safety and prevention of complications. World J Gastroenterol. 2012;18(34):4659–76.CrossRefGoogle Scholar
  35. 35.
    Ahmed K, Sussman JJ, Wang J, Schmulewitz N. A case of EUS-guided FNA-related pancreatic cancer metastasis to the stomach. Gastrointest Endosc. 2011;74(1):231–3.CrossRefGoogle Scholar
  36. 36.
    Paquin SC, Gariepy G, Lepanto L, Bourdages R, Raymond G, Sahai AV. A first report of tumor seeding because of EUS-guided FNA of a pancreatic adenocarcinoma. Gastrointest Endosc. 2005;61(4):610–1.CrossRefGoogle Scholar
  37. 37.
    Ngamruengphong S, Swanson KM, Shah ND, Wallace MB. Preoperative endoscopic ultrasound-guided fine needle aspiration does not impair survival of patients with resected pancreatic cancer. Gut. 2015;64(7):1105–10.CrossRefGoogle Scholar
  38. 38.
    Brais RJ, Davies SE, O'Donovan M, Simpson BW, Cook N, Darbonne WC, et al. Direct histological processing of EUS biopsies enables rapid molecular biomarker analysis for interventional pancreatic cancer trials. Pancreatology. 2012;12(1):8–15.CrossRefGoogle Scholar
  39. 39.
    Tada M, Komatsu Y, Kawabe T, Sasahira N, Isayama H, Toda N, et al. Quantitative analysis of K-ras gene mutation in pancreatic tissue obtained by endoscopic ultrasonography-guided fine needle aspiration: clinical utility for diagnosis of pancreatic tumor. Am J Gastroenterol. 2002;97(9):2263–70.CrossRefGoogle Scholar
  40. 40.
    Vila-Navarro E, Vila-Casadesus M, Moreira L, Duran-Sanchon S, Sinha R, Gines A, et al. Micro RNAs for detection of pancreatic neoplasia: biomarker discovery by next-generation sequencing and validation in 2 independent cohorts. Ann Surg. 2016;8:1048.Google Scholar
  41. 41.
    Frampton AE, Krell J, Mato Prado M, Gall TM, Abbassi-Ghadi N, Del Vecchio Blanco G, et al. Prospective validation of microRNA signatures for detecting pancreatic malignant transformation in endoscopic-ultrasound guided fine-needle aspiration biopsies. Oncotarget. 2016;7:28556.CrossRefGoogle Scholar
  42. 42.
    Gleeson FC, Kerr SE, Kipp BR, Voss JS, Minot DM, Tu ZJ, et al. Targeted next generation sequencing of endoscopic ultrasound acquired cytology from ampullary and pancreatic adenocarcinoma has the potential to aid patient stratification for optimal therapy selection. Oncotarget. 2016;7:54526.CrossRefGoogle Scholar
  43. 43.
    Committee ASoP, Muthusamy VR, Chandrasekhara V, Acosta RD, Bruining DH, Chathadi KV, et al. The role of endoscopy in the diagnosis and treatment of cystic pancreatic neoplasms. Gastrointest Endosc. 2016;84(1):1–9.CrossRefGoogle Scholar
  44. 44.
    Brugge WR, Lewandrowski K, Lee-Lewandrowski E, Centeno BA, Szydlo T, Regan S, et al. Diagnosis of pancreatic cystic neoplasms: a report of the cooperative pancreatic cyst study. Gastroenterology. 2004;126(5):1330–6.CrossRefGoogle Scholar
  45. 45.
    Kim KW, Park SH, Pyo J, Yoon SH, Byun JH, Lee MG, et al. Imaging features to distinguish malignant and benign branch-duct type intraductal papillary mucinous neoplasms of the pancreas: a meta-analysis. Ann Surg. 2014;259(1):72–81.CrossRefGoogle Scholar
  46. 46.
    van der Waaij LA, van Dullemen HM, Porte RJ. Cyst fluid analysis in the differential diagnosis of pancreatic cystic lesions: a pooled analysis. Gastrointest Endosc. 2005;62(3):383–9.CrossRefGoogle Scholar
  47. 47.
    Crippa S, Bassi C, Salvia R, Malleo G, Marchegiani G, Rebours V, et al. Low progression of intraductal papillary mucinous neoplasms with worrisome features and high-risk stigmata undergoing non-operative management: a mid-term follow-up analysis. Gut. 2017;66(3):495–506.CrossRefGoogle Scholar
  48. 48.
    Del Chiaro M, Verbeke C, Salvia R, Kloppel G, Werner J, McKay C, et al. European experts consensus statement on cystic tumours of the pancreas. Dig Liver Dis. 2013;45(9):703–11.CrossRefGoogle Scholar
  49. 49.
    Springer S, Wang Y, Dal Molin M, Masica DL, Jiao Y, Kinde I, et al. A combination of molecular markers and clinical features improve the classification of pancreatic cysts. Gastroenterology. 2015;149(6):1501–10.CrossRefGoogle Scholar
  50. 50.
    Jais B, Rebours V, Malleo G, Salvia R, Fontana M, Maggino L, et al. Serous cystic neoplasm of the pancreas: a multinational study of 2,622 patients under the auspices of the international association of pancreatology and European pancreatic club (European Study Group on Cystic Tumors of the Pancreas). Gut. 2016;65(2):305–12.CrossRefGoogle Scholar
  51. 51.
    Konda VJ, Meining A, Jamil LH, Giovannini M, Hwang JH, Wallace MB, et al. A pilot study of in vivo identification of pancreatic cystic neoplasms with needle-based confocal laser endomicroscopy under endosonographic guidance. Endoscopy. 2013;45(12):1006–13.CrossRefGoogle Scholar
  52. 52.
    Napoleon B, Lemaistre AI, Pujol B, Caillol F, Lucidarme D, Bourdariat R, et al. A novel approach to the diagnosis of pancreatic serous cystadenoma: needle-based confocal laser endomicroscopy. Endoscopy. 2015;47(1):26–32.PubMedGoogle Scholar
  53. 53.
    Canto MI, Harinck F, Hruban RH, Offerhaus GJ, Poley JW, Kamel I, et al. International cancer of the pancreas screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer. Gut. 2013;62(3):339–47.CrossRefGoogle Scholar
  54. 54.
    Langer P, Kann PH, Fendrich V, Habbe N, Schneider M, Sina M, et al. Five years of prospective screening of high-risk individuals from families with familial pancreatic cancer. Gut. 2009;58(10):1410–8.CrossRefGoogle Scholar
  55. 55.
    Bartsch DK, Gress TM, Langer P. Familial pancreatic cancer – current knowledge. Nat Rev Gastroenterol Hepatol. 2012;9(8):445–53.CrossRefGoogle Scholar
  56. 56.
    Bartsch DK, Slater EP, Carrato A, Ibrahim IS, Guillen-Ponce C, Vasen HF, et al. Refinement of screening for familial pancreatic cancer. Gut. 2016;65:1314.CrossRefGoogle Scholar
  57. 57.
    Vasen H, Ibrahim I, Ponce CG, Slater EP, Matthai E, Carrato A, et al. Benefit of surveillance for pancreatic cancer in high-risk individuals: outcome of long-term prospective follow-up studies from three European expert centers. J Clin Oncol. 2016;34(17):2010–9.CrossRefGoogle Scholar
  58. 58.
    Levy MJ, Wiersema MJ. Endoscopic ultrasound-guided pain control for intra-abdominal cancer. Gastroenterol Clin N Am. 2006; 35(1):153–65, x.CrossRefGoogle Scholar
  59. 59.
    Gress F, Schmitt C, Sherman S, Ikenberry S, Lehman G. A prospective randomized comparison of endoscopic ultrasound- and computed tomography-guided celiac plexus block for managing chronic pancreatitis pain. Am J Gastroenterol. 1999;94(4):900–5.CrossRefGoogle Scholar
  60. 60.
    Wyse JM, Carone M, Paquin SC, Usatii M, Sahai AV. Randomized, double-blind, controlled trial of early endoscopic ultrasound-guided celiac plexus neurolysis to prevent pain progression in patients with newly diagnosed, painful, inoperable pancreatic cancer. J Clin Oncol. 2011;29(26):3541–6.CrossRefGoogle Scholar
  61. 61.
    Fujii L, Clain JE, Morris JM, Levy MJ. Anterior spinal cord infarction with permanent paralysis following endoscopic ultrasound celiac plexus neurolysis. Endoscopy. 2012;44(Suppl 2 UCTN):E265–6.PubMedGoogle Scholar
  62. 62.
    Loeve US, Mortensen MB. Lethal necrosis and perforation of the stomach and the aorta after multiple EUS-guided celiac plexus neurolysis procedures in a patient with chronic pancreatitis. Gastrointest Endosc. 2013;77(1):151–2.CrossRefGoogle Scholar
  63. 63.
    Jang HY, Cha SW, Lee BH, Jung HE, Choo JW, Cho YJ, et al. Hepatic and splenic infarction and bowel ischemia following endoscopic ultrasound-guided celiac plexus neurolysis. Clin Endosc. 2013;46(3):306–9.CrossRefGoogle Scholar
  64. 64.
    Park WG, Yan BM, Schellenberg D, Kim J, Chang DT, Koong A, et al. EUS-guided gold fiducial insertion for image-guided radiation therapy of pancreatic. Cancer: 50 successful cases without fluoroscopy. Gastrointest Endosc. 2010;71(3):513–8.CrossRefGoogle Scholar
  65. 65.
    Luz LP, Al-Haddad MA, Sey MS, DeWitt JM. Applications of endoscopic ultrasound in pancreatic cancer. World J Gastroenterol. 2014;20(24):7808–18.CrossRefGoogle Scholar
  66. 66.
    Jin Z, Du Y, Li Z, Jiang Y, Chen J, Liu Y. Endoscopic ultrasonography-guided interstitial implantation of iodine 125-seeds combined with chemotherapy in the treatment of unresectable pancreatic carcinoma: a prospective pilot study. Endoscopy. 2008;40(4):314–20.CrossRefGoogle Scholar
  67. 67.
    Du Y, Jin Z, Jin H, Meng H, Zou D, Chen J, et al. Long-term effect of gemcitabine-combined endoscopic ultrasonography-guided brachytherapy in pancreatic cancer. J Interv Gastroenterol. 2013;3(1):18–24.CrossRefGoogle Scholar
  68. 68.
    Chang KJ, Nguyen PT, Thompson JA, Kurosaki TT, Casey LR, Leung EC, et al. Phase I clinical trial of allogeneic mixed lymphocyte culture (cytoimplant) delivered by endoscopic ultrasound-guided fine-needle injection in patients with advanced pancreatic carcinoma. Cancer. 2000;88(6):1325–35.CrossRefGoogle Scholar
  69. 69.
    Hirooka Y, Itoh A, Kawashima H, Hara K, Nonogaki K, Kasugai T, et al. A combination therapy of gemcitabine with immunotherapy for patients with inoperable locally advanced pancreatic cancer. Pancreas. 2009;38(3):e69–74.CrossRefGoogle Scholar
  70. 70.
    Herman JM, Wild AT, Wang H, Tran PT, Chang KJ, Taylor GE, et al. Randomized phase III multi-institutional study of TNFerade biologic with fluorouracil and radiotherapy for locally advanced pancreatic cancer: final results. J Clin Oncol. 2013;31(7):886–94.CrossRefGoogle Scholar
  71. 71.
    Khashab MA, Dewitt J. EUS-guided biliary drainage: is it ready for prime time? Yes! Gastrointest Endosc. 2013;78(1):102–5.CrossRefGoogle Scholar
  72. 72.
    Park do H, Jeong SU, Lee BU, Lee SS, Seo DW, Lee SK, et al. Prospective evaluation of a treatment algorithm with enhanced guidewire manipulation protocol for EUS-guided biliary drainage after failed ERCP (with video). Gastrointest Endosc. 2013;78(1):91–101.CrossRefGoogle Scholar
  73. 73.
    Itoi T, Ishii K, Tanaka R, Umeda J, Tonozuka R. Current status and perspective of endoscopic ultrasonography-guided gastrojejunostomy: endoscopic ultrasonography-guided double-balloon-occluded gastrojejunostomy (with videos). J Hepatobiliary Pancreat Sci. 2015;22(1):3–11.CrossRefGoogle Scholar
  74. 74.
    Khashab MA, Kumbhari V, Grimm IS, Ngamruengphong S, Aguila G, El Zein M, et al. EUS-guided gastroenterostomy: the first U.S. clinical experience (with video). Gastrointest Endosc. 2015;82(5):932–8.CrossRefGoogle Scholar
  75. 75.
    DeWitt J, McGreevy K, Schmidt CM, Brugge WR. EUS-guided ethanol versus saline solution lavage for pancreatic cysts: a randomized, double-blind study. Gastrointest Endosc. 2009;70(4):710–23.CrossRefGoogle Scholar
  76. 76.
    Oh HC, Seo DW, Song TJ, Moon SH, Park DH, Soo Lee S, et al. Endoscopic ultrasonography-guided ethanol lavage with paclitaxel injection treats patients with pancreatic cysts. Gastroenterology. 2011;140(1):172–9.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Gastroenterology, Endocrinology, Metabolism and InfectiologyPhilipps University MarburgMarburgGermany

Section editors and affiliations

  • James L. Abbruzzese
    • 1
  • Raul A. Urrutia
    • 2
  • John Neoptolemos
    • 3
  • Markus W. Büchler
    • 4
  1. 1.Duke University Medical CenterDurhamUSA
  2. 2.Mayo Clinic Cancer CenterMayo ClinicRochesterUSA
  3. 3.Division of Surgery and OncologyUniversity of LiverpoolLiverpoolUK
  4. 4.Department of General, Visceral and Transplantation SurgeryUniversity of HeidelbergHeidelbergGermany

Personalised recommendations